Who owns Carmell Therapeutics Corp - US?

Tip: Access positions for across all investors

Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Carmell Therapeutics Corp - US stock

Who bought or sold Carmell Therapeutics Corp - US this quarter?

Fund or Company Name
Shares Held
Valued At
Change in Shares
As Of
Actions
Hubbell Strickland Wealth Management 206k $83k 100% Sep 2024
 View chart
Vanguard Group 182k $242k 5% Jun 2024
 View chart
Carnegie Mellon University 103k $137k 0% Jun 2024
 View chart
Geode Capital Management 98k $39k 18% Sep 2024
 View chart
BlackRock 63k $25k 100% Sep 2024
 View chart
Northern Trust 53k $21k -2% Sep 2024
 View chart
Warberg Asset Management 45k $18k 0% Sep 2024
 View chart
OZ Management 38k $15k 100% Sep 2024
 View chart
BlackRock 36k $48k 15% Jun 2024
 View chart
Bangor Savings Bank 35k $14k 100% Sep 2024
 View chart
Commonwealth Equity Services 34k $14k 100% Sep 2024
 View chart
St. Denis J. Villere & Co 18k $7.1k 100% Sep 2024
 View chart
Virtu Financial 11k $4.0k 100% Sep 2024
 View chart
Tower Research Capital 2.2k $2.9k 65% Jun 2024
 View chart
Morgan Stanley 2.1k $2.8k 0% Jun 2024
 View chart
Bank of America Corporation 623.00 $249.200000 442% Sep 2024
 View chart
Wolverine Asset Management 163.00 $65.004400 100% Sep 2024
 View chart
Royal Bank of Canada 100.00 $0 100% Sep 2024
 View chart
Jpmorgan Chase & Co 33.00 $12.998700 -27% Sep 2024
 View chart

Who sold out of Carmell Therapeutics Corp - US?

Fund or Company Name
Date Sold
Shares Held
Valued At
Capital Advisors Jun 2024 89.00 $0